Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography. (Q55478651)

12 July 2018

title

Determination of 4-hydroxyifosfamide in biological matrices by high-performance liquid chromatography. (English)

1 reference

12 July 2018

high-performance liquid chromatography

main subject

1 reference

Kaijser GP

1

1 reference

12 July 2018

Ter Riet PG

2

1 reference

12 July 2018

de Kraker J

3

1 reference

12 July 2018

Bult A

4

1 reference

12 July 2018

Beijnen JH

5

1 reference

12 July 2018

Underberg WJ

6

1 reference

12 July 2018

publication date

1 March 1997

1 reference

12 July 2018

number of pages

9

1 reference

Journal of Pharmaceutical and Biomedical Analysis

inferred from page(s)

published in

1 reference

12 July 2018

volume

15

1 reference

12 July 2018

issue

6

1 reference

12 July 2018

page(s)

773-781

1 reference

12 July 2018

describes a project that uses

high-performance liquid chromatography

1 reference

Comparative study on human pharmacokinetics of activated ifosfamide and cyclophosphamide by a modified fluorometric test

inferred from title

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

[Blood level and urinary excretion of activated cyclophosphamide and its deactivation products in man (author's transl)]

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Repeated high-dose cyclophosphamide administration in bone marrow transplantation: exposure to activated metabolites

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Fluorometric determination of 4-hydroxyifosfamide in blood and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Fluorometric determination of acrolein and related compounds with m-aminophenol

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Metabolism and pharmacokinetics of oral and intravenous ifosfamide

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

In situ preparation and fate of cis-4-hydroxycyclophosphamide and aldophosphamide: 1H and 31P NMR evidence for equilibration of cis- and trans-4-hydroxycyclophosphamide with aldophosphamide and its hydrate in aqueous solution

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

The Skraup reaction with m-substituted anilines

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

High-performance liquid chromatographic method for quantitation of acrolein in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

4-hydroperoxidatin in the Fenton oxidation of the antitumor agent cyclophosphamide.

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Determination of free acetaldehyde in blood as the dinitrophenylhydrazone derivative by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Gas chromatographic determination of ifosfamide in microvolumes of urine and plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

Gas chromatographic determination of 2- and 3-dechloroethylifosfamide in plasma and urine

1 reference

https://api.crossref.org/works/10.1016%2FS0731-7085%2896%2901893-6

7 January 2021

10.1016/S0731-7085(96)01893-6

Identifiers

DOI

1 reference

12 July 2018

1 reference

12 July 2018